Literature DB >> 15188379

Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice.

Alfons S K de Hooge1, Fons A J van de Loo, Marije I Koenders, Miranda B Bennink, Onno J Arntz, Thomas Kolbe, Wim B van den Berg.   

Abstract

OBJECTIVE: STAT proteins play an important role in cytokine signaling. Some investigators have reported preferential activation of STAT-1, and others have reported preferential activation of STAT-3, in response to endogenous interleukin-6 (IL-6), in patients with rheumatoid arthritis. The present study was undertaken to investigate synovial STAT-1 and STAT-3 activation in an experimental animal model of arthritis.
METHODS: Zymosan was injected intraarticularly into naive wild-type (WT), IL-6(-/-), and STAT-1(-/-) mice to induce arthritis. Western blots of synovial lysates were probed with phosphospecific antibodies to detect STAT-1/STAT-3 activation. Inflammation was assessed histologically. Synovial gene expression of the STAT-induced feedback inhibitors suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 in WT and STAT-1(-/-) mice was investigated by reverse transcriptase-polymerase chain reaction.
RESULTS: STAT-3 was activated in inflamed synovium of WT mice throughout the course of disease, whereas activated STAT-1 was observed only during the chronic phase. In IL-6(-/-) mice, STAT activation was limited to STAT-3 on day 1. Although macrophage influx was not inhibited, disease went into remission after day 7 in IL-6(-/-) mice. STAT-1 deficiency resulted in exacerbation of chronic joint inflammation and granuloma formation. In STAT-1(-/-) mice, STAT-3 activation in the inflamed joints was unaltered as compared with WT mice. However, synovial SOCS-1, but not SOCS-3, gene expression was markedly reduced in STAT-1(-/-) mice.
CONCLUSION: The results in the IL-6(-/-) mice suggest that STAT-3 is involved in the chronicity of ZIA. Exacerbation of arthritis in STAT-1(-/-) mice suggests an opposing effect of STAT-1, i.e., suppression of joint inflammation. The expression of SOCS-1 could be the underlying mechanism by which STAT-1 controls joint inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188379     DOI: 10.1002/art.20302

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  32 in total

1.  Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells.

Authors:  M Canavan; V Marzaioli; T McGarry; V Bhargava; S Nagpal; D J Veale; U Fearon
Journal:  Clin Exp Immunol       Date:  2020-07-15       Impact factor: 4.330

Review 2.  Negative regulation of cytokine signaling.

Authors:  Akihiko Yoshimura
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

3.  Dietary extra-virgin olive oil prevents inflammatory response and cartilage matrix degradation in murine collagen-induced arthritis.

Authors:  María Angeles Rosillo; Marina Sánchez-Hidalgo; Susana Sánchez-Fidalgo; Marina Aparicio-Soto; Isabel Villegas; Catalina Alarcón-de-la-Lastra
Journal:  Eur J Nutr       Date:  2015-02-10       Impact factor: 5.614

4.  Curcumin abrogates LPS-induced pro-inflammatory cytokines in RAW 264.7 macrophages. Evidence for novel mechanisms involving SOCS-1, -3 and p38 MAPK.

Authors:  Morgana Rodrigues Guimarães; Fábio Renato Manzoli Leite; Luís Carlos Spolidorio; Keith Lough Kirkwood; Carlos Rossa
Journal:  Arch Oral Biol       Date:  2013-08-23       Impact factor: 2.633

5.  Effects of miR-150-5p on the growth and SOCS1 expression of rheumatoid arthritis synovial fibroblasts.

Authors:  Mingliang Qiu; Lisha Mo; Juxiang Li; Hua Liang; Weina Zhu; Xiangjuan Zheng; Xinwang Duan; Weidong Xu
Journal:  Clin Rheumatol       Date:  2019-12-26       Impact factor: 2.980

Review 6.  Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.

Authors:  Simon A Jones; Jürgen Scheller; Stefan Rose-John
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

7.  DNA methylation analysis of SOCS1, SOCS3, and LINE-1 in microdissected gingival tissue.

Authors:  Denise C Andia; Aline C Planello; Danielle Portinho; Rodrigo A da Silva; Cristiane R Salmon; Enilson A Sallum; Francisco H Nociti Junior; Ana P de Souza
Journal:  Clin Oral Investig       Date:  2015-04-07       Impact factor: 3.573

Review 8.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

9.  Anti-arthritis effects of (E)-2,4-bis(p-hydroxyphenyl)-2-butenal are mediated by inhibition of the STAT3 pathway.

Authors:  Jung Ok Ban; Dae Hwan Kim; Hee Pom Lee; Chul Ju Hwang; Jung-Hyun Shim; Dae Joong Kim; Tae Myoung Kim; Heon-Sang Jeong; Seong Su Nah; Hanyong Chen; Zigang Dong; Young Wan Ham; Youngsoo Kim; Sang-Bae Han; Jin Tae Hong
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  Computational design and application of endogenous promoters for transcriptionally targeted gene therapy for rheumatoid arthritis.

Authors:  Jeroen Geurts; Leo A B Joosten; Nozomi Takahashi; Onno J Arntz; Anton Glück; Miranda B Bennink; Wim B van den Berg; Fons A J van de Loo
Journal:  Mol Ther       Date:  2009-08-18       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.